What is the size of the Bioprocessing Market?
According to 6Wresearch internal database and industry insights, the Global Bioprocessing Market was demonstrated around USD 24 billion in 2024 and is projected to reach USD 60 billion by 2031, growing at a CAGR of 14.1% during the forecast period 2025–2031.
Due to rising biopharmaceutical production, expansion in biosimilars, and increased adoption of single-use technologies across biomanufacturing, the market is continued to rise in the future.
Key Growth Factors of the Bioprocessing Market
- Surge in biologics and biosimilar production globally
- Growing demand for vaccines, monoclonal antibodies, and cell therapies
- Advancements in upstream and downstream processing technologies
- Expansion of CDMO and CRO facilities in emerging markets
- Increasing focus on process efficiency, scalability, and cost reduction
Bioprocessing Market Trends
Bioprocessing market is witnessed for the numbers of emerging trends include the widespread shift toward single-use bioreactors and continuous Bioprocessing systems to boost flexibility and reduce contamination risks. Other notable trend is the Automation, AI, and real-time process analytics (PAT) are becoming standard for improving yield and consistency. Further, the modular Bioprocessing facilities are also on the rise which enables the faster deployment and decentralized manufacturing capabilities.
Emerging Developments in the Bioprocessing Market
The Bioprocessing market is seeing few developments such as the integration of digital twins and AI-powered Bioprocessing modelling to optimize production and minimize downtime. Novel cell lines and genetically engineered host cells are improving productivity, while 3D-printed Bioprocessing equipment is being explored for customized applications. Now, the companies are also developing next-gen perfusion systems and advanced chromatography techniques to streamline downstream purification.
Leading Companies in the Bioprocessing Market
- Sartorius AG
- Thermo Fisher Scientific
- Danaher Corporation
- Merck KGaA
- Eppendorf AG
- GE Healthcare Life Sciences (Cytiva)
- Lonza Group
- Repligen Corporation
- Corning Inc.
- PBS Biotech
How big is the Bioprocessing Market : FAQs
The Bioprocessing Ing market was estimated at USD 24 billion in 2024.
Biopharma, vaccines, cell & gene therapy, and contract manufacturing organizations (CMOs) are main industries.
Rising biologics demand, scalable manufacturing needs, and technology advancements.
Sartorius, Thermo Fisher, Danaher, Merck, and Cytiva lead the industry.
Bioprocessing Ing market is expected to is projected to reach USD 60 billion by 2031.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com